
Small-Molecule Tumor-Targeting [9 9mTc] Agents for Breast Cancer ImagingAward last edited on: 4/1/2002
Sponsored Program
SBIRAwarding Agency
DOETotal Award Amount
$100,000Award Phase
1Solicitation Topic Code
-----Principal Investigator
Biao YangCompany Information
Anasazi Biomedical Research Inc
Albert Hall Suite 206
Winston-Salem, NC 27101
Winston-Salem, NC 27101
(336) 721-9071 |
N/A |
N/A |
Location: Single
Congr. District: 05
County: Forsyth
Congr. District: 05
County: Forsyth
Phase I
Contract Number: ----------Start Date: ---- Completed: ----
Phase I year
2000Phase I Amount
$100,000Commercial Applications and Other Benefits as described by the awardee:
The product developed in this Phase I SBIR project is a tumor-targeting non-invasive imaging technique that will benefit breast cancer patients in treatment strategy planning and long-term disease control by providing vital information regarding the proliferative status of the tumor. It can also be used as a breast cancer screening technique, which will greatly improve the efficiency and accuracy of the tumor detection. The technique developed in this Phase I SBIR project can also be translated into other area of cancer diagnosis and patient management such as lung cancer, glioblastoma, melanoma, head and neck cancers. The product processes a strong commercial potential because of the widespread availability and low-cost of technetium-99m generators and scanners throughout the country.
Phase II
Contract Number: ----------Start Date: ---- Completed: ----